SCYX
SCYNEXIS Inc. Common Stock
$0.822+-0.000 (-0.000%)
Real-time Price
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.822
High
$0.822
Low
$0.822
Volume
0.05M
Company Fundamentals
Trading Stats
Related News
GlobeNewswire
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical holdResumption of dosing in this study triggers a $10M milestone payment from GSK plus an additional $20M milestone due in six
View more
GlobeNewswire
SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update
Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme.Hansoh recently
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.